Skip to content

A clinical study evaluating the safety and effectiveness of an artificial intelligence- and ultrasound-based venipuncture assistance medical device compared with manual venipuncture

A Single-Center, Randomized, Crossover, Prospective, Open-Label, Non-Inferiority Confirmatory Clinical Trial to Evaluate the Safety and Efficacy of an AI- and Ultrasound-Based Medical Device that Assists Venipuncture, Compared with Manual Venipuncture

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0011541
Enrollment
190
Registered
2026-01-27
Start date
2026-01-26
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : - Device name/model: AIIV L2 - Product code: H2BXXA2 - Intended use: This medical device is intended for use by healthcare professionals in medical institutions to obtain ultrasound i

Sponsors

AIRS Medical Inc.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion Criteria Subjects who meet all of the following criteria will be included: - Male or female adults aged 19 years or older at the time of study enrollment. - Subjects who are able to undergo venipuncture in the antecubital area of both arms, without restriction of elbow joint movement, and who can maintain the arm in a stable extended position during venipuncture. - Subjects who have received a full explanation of the clinical trial, fully understand the contents, voluntarily decide to participate, and provide written informed consent prior to screening procedures.

Exclusion criteria

Exclusion criteria: Exclusion Criteria Subjects who meet any of the following criteria will be excluded: - Pregnant or breastfeeding women. - Subjects with an implanted defibrillator or pacemaker. - Subjects at increased risk of bleeding due to underlying conditions such as anticoagulant use, hemophilia, thrombocytopenia, preeclampsia, or other coagulation disorders. - Subjects with abnormal vascular anatomy in the antecubital area due to vascular malformations, vascular disease, or prior creation of an arteriovenous shunt. - Subjects with significant abnormal skin lesions (e.g., infection, dermatologic disease, trauma, or wounds) in the antecubital area. - Subjects whose arm condition is unsuitable for venipuncture due to transfusion, intravenous fluid therapy, or similar procedures. - Subjects with immunodeficiency or immunosuppression (e.g., steroid or immunosuppressant therapy, severe infection) and therefore vulnerable to infection. - Subjects with a prior history of severe vasovagal reaction during venipuncture. - Subjects whose upper arm circumference exceeds 44 cm, preventing application of the tourniquet inside the device. - Subjects with a conflict of interest, such as employees of competing companies. - Subjects considered by the investigator to be otherwise unsuitable for participation in this clinical trial.

Design outcomes

Primary

MeasureTime frame
Venipuncture success rate

Secondary

MeasureTime frame
Procedure time;Hemolysis rate;Pain score during device-assisted venipuncture (NRS);Within-subject comparison of pain scores between device-assisted venipuncture and manual venipuncture.;Assessment of participants’ willingness to undergo venipuncture again using the device.;Incidence of venipuncture-related adverse events

Countries

Korea, Republic of

Contacts

Public ContactSang Hoon Song

Seoul National University Hospital

cloak21@snu.ac.kr+82-2-2072-3326

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 7, 2026